Skip to main content
Focused investors/Bill Ackman

Bill Ackman - Pershing Square Capital Management

As of Q2 2026, Bill Ackman reported 14 long-equity positions worth $19.47B in aggregate.

Copy-investor backtest

Latest quarter
+1.96%
1-year
+15.11%
3-year
+41.35%
5-year
+50.23%
3-year vs S&P 500
-31.89%
5-year vs S&P 500
-23.45%
5-year top 5
+52.69%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when Bill Ackman files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 4 of 8 rows. Rows without a quote are marked unavailable.

1VRXVALEANT PHARMACEUTICALS INTL29.95%-19,473,933$4.33BNo quoteNo quote
2APDAIR PRODS & CHEMS INC19.46%-20,549,076$2.81B$136.83No quote
3CPCANADIAN PAC RY LTD15.46%-13,940,890$2.23B$160.23No quote
4ZTSZOETIS INC13.96%-41,823,145$2.02B$48.22No quote
5QSRRESTAURANT BRANDS INTL INC10.05%-38,003,984$1.45B$38.21No quote
6PAHPLATFORM SPECIALTY PRODS COR7.57%-42,737,394$1.09BNo quoteNo quote
7HHCHOWARD HUGHES CORP3.55%-3,568,017$512.15MNo quoteNo quote
8ACTZZZZACTAVIS PLC-Sold0$0No quoteNo quote